Anti-NMDA Receptor Encephalitis in a 14-Year-Old Female Presenting as Malignant Catatonia: Medical and Psychiatric Approach to Treatment

Psychosomatics

Volumn 54, Issue 6, 2013, Pages 585-589

  Wilson, Jo Ellen ^a   Shuster, John ^a,b   Fuchs, Catherine ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Alive Hospice   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CLONIDINE; ETIRACETAM; HALOPERIDOL; IMMUNOGLOBULIN; LORAZEPAM; NEUROLEPTIC AGENT; PROPRANOLOL; RITUXIMAB; STEROID; VALPROIC ACID; ZOLPIDEM;

ABNORMAL POSTURE; ADOLESCENT; AFRICAN AMERICAN; AGITATION; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ANTIBIOTIC THERAPY; AROUSAL; ARTICLE; ASPIRATION PNEUMONIA; AUTONOMIC NEUROPATHY; BLOOD PRESSURE; BRAIN DISEASE; BRAIN STEM RESPONSE; CASE REPORT; CATATONIA; CHILD PSYCHIATRY; CLINICAL FEATURE; CLONUS; COMA; COMPUTER ASSISTED TOMOGRAPHY; CORE TEMPERATURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; ECHOLALIA; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; EMERGENCY WARD; ENCEPHALITIS; FACE ASYMMETRY; FATIGUE; FEMALE; FEVER; FOLLOW UP; GESTURE; GLASGOW COMA SCALE; HEADACHE; HERPES SIMPLEX ENCEPHALITIS; HOSPICE CARE; HUMAN; HYPERTENSION; IMMOBILITY; INSOMNIA; INTENSIVE CARE UNIT; LUMBAR PUNCTURE; MALIGNANT CATATONIA; MENTAL HEALTH; MONONUCLEOSIS; MOVEMENT (PHYSIOLOGY); MUSCLE HYPERTONIA; MUSCLE RIGIDITY; MUTISM; NEUROLEPTIC MALIGNANT SYNDROME; NEUROLOGIST; NOCICEPTIVE STIMULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY TERATOMA; PARANEOPLASTIC NEUROPATHY; PARENTERAL NUTRITION; PEDIATRIC ADVANCED LIFE SUPPORT; PHYSIOTHERAPIST; PNEUMONIA; PSYCHIATRIC TREATMENT; PSYCHOSIS; RESPIRATORY DRIVE; SALPINGOOOPHORECTOMY; SEIZURE; SOMNOLENCE; STEREOTYPY; STIMULUS RESPONSE; STOMACH TUBE; STUPOR; TACHYCARDIA; TERATOMA; THORAX RADIOGRAPHY; TRACHEOSTOMY; VERBALIZATION; WEAKNESS; WEIGHT REDUCTION;

ADOLESCENT; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CATATONIA; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; OVARIAN NEOPLASMS; TERATOMA;

EID: 84887609629     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2013.03.002     Document Type: Article

References (18)

1. Vitaliani R., Mason W., Ances B., Zwerdling T., Jiang Z., Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 2005, 58(4):594-604.
2. Florance N.R., Davis R.L., Lam C., et al. Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009, 66(1):11-18.
3. Florance-Ryan N., Dalmau J. Update on anti-N-methyl-d-aspartate receptor encephalitis in children and adolescents. Curr Opin Pediatr 2010, 22(6):739-744.
4. Dalmau J., Lancaster E., Martinez-Hernandez E., Rosenfeld M.R., Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2001, 10(1):63-74.
5. Seiki M., Suzuki S.Izuka, Shimizu T., et al. Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry 2008, 79(3):324-326.
6. Cohen D., Flament M., Dubos P.F., Basquin M. Case Series: catatonic syndrome in young people. J Am Acad Child Adolesc Psychiatry 1999, 38(8):1040-1046.
7. Rey J.M., Walter G. Half a century of ECT use in young people. Am J Psychiatry 1997, 154(5):595-602.
8. Duffett R., Hill P., Lelliott P. Use of electroconvulsive therapy in young people. Br J Psychiatry 1999, 175:228-230.
9. Ghaziuddin N., Alkhouri I., Champine D., Quinlan P., Fluent T., Ghaziuddin M. ECT treatment of malignant catatonia/NMS in an adolescent: a useful lesson in delayed diagnosis and treatment. J ECT 2002, 18(2):95-98.
10. Consoli A., Ronen K., An-Goufinkel I., et al. Malignant catatonia due to anti-NMDA-receptor encephalitis in a 17-year-old girl: case report. Child Adolesc Psychiatry Ment Health 2011, 5(1):15.
11. Waxman E.A., Lynch D.R. N-methyl-d-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist 2005, 11(1):37-49.
12. Dalmau J., Gleichman A.J., Hughes E.G., et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008, 7(12):1091-1098.
13. Barry H., Hardiman O., Healy D.G., et al. Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis. Br J Psychiatry 2011, 199(6):508-509.
14. Lee A., Glick D.B., Dinwiddie S.H. Electroconvulsive therapy in a pediatric patient with malignant catatonia and paraneoplastic limbic encephalitis. J ECT 2006, 22(4):267-270.
15. Slooter A.J.C., Braun K.P.J., Balk F.J., van Nieuwenhuizen O., vand der Hoeven J Electroconvulsive therapy for malignant catatonia in childhood. Pediatr Neurol 2005, 32(3):190-192.
16. Braakman H.M., Moers-Hornikx V.M., Arts B.M., Hupperts R.M., Nicolai J. Pearls and oy-sters: electroconvulsive therapy in anti-NMDA receptor encephalitis. Neurology 2010, 75(10):e44-e46.
17. Maurer M.A., Rakocevic G., Leung C.S., et al. Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity. J Clin Invest 2012, 122(4):1393-1402.
18. Watkins C.J., Pei Q., Newberry N.R. Differential effects of electroconvulsive shock on the glutamate receptor mRNAs for NR2A, NR2B and mGluR5b. Brain Res Mol Brain Res 1998, 61(1-2):108-113.